1. Home
  2. CCEL vs MAMK Comparison

CCEL vs MAMK Comparison

Compare CCEL & MAMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • MAMK
  • Stock Information
  • Founded
  • CCEL 1989
  • MAMK 2007
  • Country
  • CCEL United States
  • MAMK China
  • Employees
  • CCEL N/A
  • MAMK N/A
  • Industry
  • CCEL Managed Health Care
  • MAMK Apparel
  • Sector
  • CCEL Health Care
  • MAMK Consumer Discretionary
  • Exchange
  • CCEL Nasdaq
  • MAMK Nasdaq
  • Market Cap
  • CCEL 36.7M
  • MAMK 43.2M
  • IPO Year
  • CCEL 1997
  • MAMK 2025
  • Fundamental
  • Price
  • CCEL $4.72
  • MAMK $2.16
  • Analyst Decision
  • CCEL Strong Buy
  • MAMK
  • Analyst Count
  • CCEL 1
  • MAMK 0
  • Target Price
  • CCEL $8.50
  • MAMK N/A
  • AVG Volume (30 Days)
  • CCEL 17.6K
  • MAMK 92.8K
  • Earning Date
  • CCEL 10-14-2025
  • MAMK 01-01-0001
  • Dividend Yield
  • CCEL 12.77%
  • MAMK N/A
  • EPS Growth
  • CCEL N/A
  • MAMK N/A
  • EPS
  • CCEL N/A
  • MAMK 0.12
  • Revenue
  • CCEL $31,988,783.00
  • MAMK $21,434,100.00
  • Revenue This Year
  • CCEL $1.75
  • MAMK N/A
  • Revenue Next Year
  • CCEL N/A
  • MAMK N/A
  • P/E Ratio
  • CCEL N/A
  • MAMK $17.87
  • Revenue Growth
  • CCEL 1.10
  • MAMK N/A
  • 52 Week Low
  • CCEL $4.09
  • MAMK $1.87
  • 52 Week High
  • CCEL $9.43
  • MAMK $4.00
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 51.06
  • MAMK N/A
  • Support Level
  • CCEL $4.21
  • MAMK N/A
  • Resistance Level
  • CCEL $4.82
  • MAMK N/A
  • Average True Range (ATR)
  • CCEL 0.26
  • MAMK 0.00
  • MACD
  • CCEL 0.03
  • MAMK 0.00
  • Stochastic Oscillator
  • CCEL 84.00
  • MAMK 0.00

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About MAMK MaxsMaking Inc. Class A Ordinary Shares

MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.

Share on Social Networks: